HGF and breast cancer: The hepatocyte growth factor (HGF)/MET pathway plays a role that appears could be essential in at least some BC recurrence, a contention further supported with evidence obtained by MET immunostaining in primary human donor BC samples, especially when reconstructive fat grafts are used with surgical resection, [33].